 Teresa Sharp
Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Public-Private Sector Partnerships | 1 | 2019 | 42 | 0.640 |
Why?
| | Geriatric Nursing | 1 | 2019 | 22 | 0.640 |
Why?
| | Rural Health Services | 1 | 2019 | 111 | 0.610 |
Why?
| | Health Resources | 1 | 2019 | 113 | 0.610 |
Why?
| | Rural Population | 1 | 2019 | 513 | 0.490 |
Why?
| | Exercise | 13 | 2015 | 1925 | 0.470 |
Why?
| | Energy Metabolism | 14 | 2012 | 873 | 0.460 |
Why?
| | Homosexuality, Male | 1 | 2015 | 176 | 0.430 |
Why?
| | Healthcare Disparities | 1 | 2019 | 575 | 0.420 |
Why?
| | Health Services Accessibility | 1 | 2019 | 899 | 0.390 |
Why?
| | Attitude to Health | 1 | 2015 | 430 | 0.370 |
Why?
| | Basal Metabolism | 3 | 2006 | 58 | 0.220 |
Why?
| | Harm Reduction | 1 | 2023 | 32 | 0.210 |
Why?
| | Dietary Carbohydrates | 4 | 2006 | 151 | 0.210 |
Why?
| | Calorimetry, Indirect | 9 | 2006 | 81 | 0.200 |
Why?
| | Body Composition | 10 | 2006 | 649 | 0.200 |
Why?
| | Dietary Fats | 5 | 2006 | 301 | 0.200 |
Why?
| | Substance Abuse, Intravenous | 1 | 2023 | 108 | 0.190 |
Why?
| | Obesity | 8 | 2012 | 2879 | 0.190 |
Why?
| | Health Policy | 1 | 2023 | 351 | 0.170 |
Why?
| | Body Weight | 5 | 2003 | 939 | 0.160 |
Why?
| | Adiponectin | 2 | 2016 | 235 | 0.140 |
Why?
| | Cholesterol | 2 | 2012 | 412 | 0.130 |
Why?
| | Human Development | 1 | 2016 | 16 | 0.130 |
Why?
| | Triglycerides | 2 | 2012 | 527 | 0.130 |
Why?
| | Adipose Tissue | 4 | 2006 | 590 | 0.130 |
Why?
| | Physical Fitness | 2 | 2000 | 203 | 0.130 |
Why?
| | Puberty | 1 | 2016 | 143 | 0.120 |
Why?
| | Diabetes Mellitus | 1 | 2003 | 1000 | 0.120 |
Why?
| | Canada | 1 | 2015 | 350 | 0.110 |
Why?
| | Fats | 3 | 2002 | 14 | 0.100 |
Why?
| | Male | 20 | 2019 | 63517 | 0.100 |
Why?
| | United States | 3 | 2023 | 13828 | 0.100 |
Why?
| | Regression Analysis | 3 | 2003 | 991 | 0.100 |
Why?
| | Hyperlipidemias | 1 | 2012 | 126 | 0.090 |
Why?
| | Thinness | 1 | 2012 | 89 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2003 | 2003 | 0.090 |
Why?
| | Self Efficacy | 1 | 2015 | 373 | 0.090 |
Why?
| | Adult | 18 | 2016 | 35497 | 0.090 |
Why?
| | Oxygen Consumption | 3 | 2008 | 672 | 0.090 |
Why?
| | Circadian Rhythm | 2 | 2005 | 413 | 0.080 |
Why?
| | Weight Loss | 2 | 2008 | 732 | 0.080 |
Why?
| | Middle Aged | 7 | 2019 | 31091 | 0.080 |
Why?
| | Physical Endurance | 3 | 2002 | 262 | 0.080 |
Why?
| | Female | 19 | 2019 | 68556 | 0.080 |
Why?
| | Oxidation-Reduction | 8 | 2005 | 1028 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 339 | 0.080 |
Why?
| | Sleep | 4 | 2008 | 684 | 0.080 |
Why?
| | Humans | 23 | 2023 | 129271 | 0.080 |
Why?
| | Energy Intake | 4 | 2008 | 461 | 0.080 |
Why?
| | Pharynx | 1 | 2008 | 58 | 0.070 |
Why?
| | Insulin Resistance | 1 | 2016 | 1165 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7055 | 0.070 |
Why?
| | Motor Activity | 1 | 2012 | 675 | 0.070 |
Why?
| | Weight Gain | 2 | 2012 | 509 | 0.070 |
Why?
| | Young Adult | 4 | 2016 | 12392 | 0.060 |
Why?
| | Carbohydrate Metabolism | 2 | 2002 | 62 | 0.060 |
Why?
| | Obesity, Morbid | 1 | 2008 | 240 | 0.060 |
Why?
| | Dietary Proteins | 1 | 2005 | 129 | 0.050 |
Why?
| | Lipoproteins, HDL | 1 | 2003 | 85 | 0.050 |
Why?
| | HIV-Associated Lipodystrophy Syndrome | 1 | 2003 | 12 | 0.050 |
Why?
| | Anthropometry | 1 | 2003 | 204 | 0.050 |
Why?
| | Body Mass Index | 4 | 2003 | 2272 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2003 | 56 | 0.050 |
Why?
| | Weight Lifting | 1 | 2002 | 34 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 5384 | 0.050 |
Why?
| | Physical Exertion | 1 | 2002 | 205 | 0.050 |
Why?
| | Body Height | 1 | 2002 | 192 | 0.050 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2001 | 97 | 0.040 |
Why?
| | Cross-Over Studies | 3 | 2012 | 521 | 0.040 |
Why?
| | Aged | 1 | 2019 | 22032 | 0.040 |
Why?
| | Sex Characteristics | 2 | 2002 | 736 | 0.040 |
Why?
| | Cooperative Behavior | 1 | 2023 | 433 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2003 | 497 | 0.040 |
Why?
| | Calorimetry | 3 | 2008 | 66 | 0.040 |
Why?
| | Adolescent | 6 | 2016 | 20315 | 0.040 |
Why?
| | Blood Pressure | 2 | 2003 | 1736 | 0.040 |
Why?
| | Bicycling | 2 | 2005 | 116 | 0.040 |
Why?
| | Blood Glucose | 2 | 2012 | 2097 | 0.040 |
Why?
| | Sex Factors | 2 | 2016 | 1965 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2016 | 5051 | 0.030 |
Why?
| | Carbon Dioxide | 2 | 2008 | 259 | 0.030 |
Why?
| | Physical Education and Training | 1 | 1994 | 75 | 0.030 |
Why?
| | Eating | 2 | 1994 | 368 | 0.030 |
Why?
| | Insulin | 3 | 2012 | 2325 | 0.030 |
Why?
| | Aerobiosis | 1 | 1992 | 22 | 0.020 |
Why?
| | Hypertension | 1 | 2001 | 1242 | 0.020 |
Why?
| | Aging | 1 | 2002 | 1774 | 0.020 |
Why?
| | Postprandial Period | 1 | 2012 | 104 | 0.020 |
Why?
| | Overnutrition | 1 | 2012 | 30 | 0.020 |
Why?
| | Area Under Curve | 1 | 2012 | 304 | 0.020 |
Why?
| | Rest | 1 | 1992 | 120 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2012 | 160 | 0.020 |
Why?
| | Body Temperature | 1 | 1992 | 212 | 0.020 |
Why?
| | Accelerometry | 1 | 2012 | 93 | 0.020 |
Why?
| | Risk Factors | 1 | 2003 | 9746 | 0.020 |
Why?
| | Diet | 3 | 2003 | 1212 | 0.020 |
Why?
| | Sleep Apnea Syndromes | 1 | 2008 | 82 | 0.020 |
Why?
| | Colorado | 1 | 2016 | 4406 | 0.020 |
Why?
| | Glucose Clamp Technique | 1 | 2006 | 194 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2005 | 120 | 0.020 |
Why?
| | Respiration | 1 | 2005 | 191 | 0.010 |
Why?
| | Linear Models | 1 | 2006 | 819 | 0.010 |
Why?
| | Lipolysis | 1 | 2003 | 41 | 0.010 |
Why?
| | Anaerobic Threshold | 1 | 2002 | 28 | 0.010 |
Why?
| | Dairy Products | 1 | 2003 | 36 | 0.010 |
Why?
| | Sampling Studies | 1 | 2002 | 96 | 0.010 |
Why?
| | Abdomen | 1 | 2003 | 117 | 0.010 |
Why?
| | CD4 Lymphocyte Count | 1 | 2003 | 266 | 0.010 |
Why?
| | Glucose Tolerance Test | 1 | 2003 | 355 | 0.010 |
Why?
| | Renin | 1 | 2001 | 32 | 0.010 |
Why?
| | Aldosterone | 1 | 2001 | 43 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 6543 | 0.010 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2001 | 47 | 0.010 |
Why?
| | Reference Values | 1 | 2002 | 793 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2006 | 1949 | 0.010 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2001 | 138 | 0.010 |
Why?
| | Kinetics | 1 | 2003 | 1644 | 0.010 |
Why?
| | Fatty Acids | 1 | 2001 | 427 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2001 | 1288 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2002 | 1839 | 0.010 |
Why?
| | Lipids | 1 | 2001 | 625 | 0.010 |
Why?
| | Heart Rate | 1 | 2001 | 802 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2740 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2006 | 4887 | 0.010 |
Why?
| | Child | 1 | 2016 | 20785 | 0.010 |
Why?
| | Proteins | 1 | 2002 | 941 | 0.010 |
Why?
| | Retrospective Studies | 1 | 1992 | 14461 | 0.010 |
Why?
| | Menstruation | 1 | 1994 | 44 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2002 | 1613 | 0.010 |
Why?
| | Nutritional Status | 1 | 1994 | 328 | 0.010 |
Why?
| | Prospective Studies | 1 | 2002 | 7123 | 0.010 |
Why?
|
|
Sharp's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|